You are here: All Products  > Shanghai Pharma Signs MOU to Develop BIOCAD's mAb Portfolio in China

Shanghai Pharma Signs MOU to Develop BIOCAD's mAb Portfolio in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.